» Articles » PMID: 30639256

Iron Oxide Nanoparticles: Diagnostic, Therapeutic and Theranostic Applications

Overview
Specialty Pharmacology
Date 2019 Jan 15
PMID 30639256
Citations 317
Authors
Affiliations
Soon will be listed here.
Abstract

Many different iron oxide nanoparticles have been evaluated over the years, for a wide variety of biomedical applications. We here summarize the synthesis, surface functionalization and characterization of iron oxide nanoparticles, as well as their (pre-) clinical use in diagnostic, therapeutic and theranostic settings. Diagnostic applications include liver, lymph node, inflammation and vascular imaging, employing mostly magnetic resonance imaging but recently also magnetic particle imaging. Therapeutic applications encompass iron supplementation in anemia and advanced cancer treatments, such as modulation of macrophage polarization, magnetic fluid hyperthermia and magnetic drug targeting. Because of their properties, iron oxide nanoparticles are particularly useful for theranostic purposes. Examples of such setups, in which diagnosis and therapy are intimately combined and in which iron oxide nanoparticles are used, are image-guided drug delivery, image-guided and microbubble-mediated opening of the blood-brain barrier, and theranostic tissue engineering. Together, these directions highlight the versatility and the broad applicability of iron oxide nanoparticles, and indicate the integration in future medical practice of multiple iron oxide nanoparticle-based materials.

Citing Articles

Application of Nanomaterials in Early Imaging and Advanced Treatment of Atherosclerosis.

Zhou Q, Wang Y, Si G, Chen X, Mu D, Zhang B Chem Biomed Imaging. 2025; 3(2):51-76.

PMID: 40018650 PMC: 11863161. DOI: 10.1021/cbmi.4c00064.


Cariogenic Microbiota and Emerging Antibacterial Materials to Combat Dental Caries: A Literature Review.

Cao J, Ma Q, Shi J, Wang X, Ye D, Liang J Pathogens. 2025; 14(2).

PMID: 40005488 PMC: 11858515. DOI: 10.3390/pathogens14020111.


Chemical Conjugation of Iron Oxide Nanoparticles for the Development of Magnetically Directable Silk Particles.

Marini A, Tomaraei G, Weinbaum J, Bedewy M, Vorp D ACS Appl Mater Interfaces. 2025; 17(6):8901-8913.

PMID: 39900356 PMC: 11826889. DOI: 10.1021/acsami.4c17536.


Optimized Synthesis and Stabilization of Superparamagnetic Iron Oxide Nanoparticles for Enhanced Biomolecule Adsorption.

Juvencio Keijok W, Contreras Alvarez L, Gomes A, Vasconcelos Campos F, de Oliveira J, Guimaraes M ACS Omega. 2025; 10(2):1976-1987.

PMID: 39866618 PMC: 11755185. DOI: 10.1021/acsomega.4c07371.


Tumor microenvironment-responsive hyperbranched polymers for controlled drug delivery.

Guo Y, He X, Williams G, Zhou Y, Liao X, Xiao Z J Pharm Anal. 2025; 14(12):101003.

PMID: 39831051 PMC: 11742316. DOI: 10.1016/j.jpha.2024.101003.


References
1.
Xia T, Kovochich M, Liong M, Meng H, Kabehie S, George S . Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano. 2009; 3(10):3273-86. PMC: 3900639. DOI: 10.1021/nn900918w. View

2.
Xu H, Cheng L, Wang C, Ma X, Li Y, Liu Z . Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. Biomaterials. 2011; 32(35):9364-73. DOI: 10.1016/j.biomaterials.2011.08.053. View

3.
Mertens M, Koch S, Schuster P, Wehner J, Wu Z, Gremse F . USPIO-labeled textile materials for non-invasive MR imaging of tissue-engineered vascular grafts. Biomaterials. 2014; 39:155-63. DOI: 10.1016/j.biomaterials.2014.10.076. View

4.
Mahmoudi M, Serpooshan V . Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano. 2012; 6(3):2656-64. DOI: 10.1021/nn300042m. View

5.
Gupta A, Gupta M . Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18):3995-4021. DOI: 10.1016/j.biomaterials.2004.10.012. View